Literature DB >> 8933046

Medical and ethical issues in genetic screening--an academic view.

N A Holtzman1.   

Abstract

This article is intended to acquaint those whose principal concerns are the health and safety of workers with genetic screening and some of the medical and ethical issues it raises. Population-based genetic screening increasingly is being considered for predicting future disease in the person being screened. A major problem in screening for alleles that contribute to the development of common, multifactorial disorders is low sensitivity and positive predictive value. In many instances, no demonstrably effective prophylaxis or treatment is available to help those with positive test results. This creates ethical problems of assuring that testing is in the person's best interest and raises in turn issues of autonomy, discrimination, and privacy. Instead of screening for genetic predispositions to harm from workplace exposures, other means of improving the health of workers may bring greater benefits to a higher proportion of workers. The current state of genetic tests for chronic beryllium disease are considered. None are suitable for screening.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Substances:

Year:  1996        PMID: 8933046      PMCID: PMC1469693          DOI: 10.1289/ehp.96104s5987

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  11 in total

1.  Genetic discrimination and the law.

Authors:  M R Natowicz; J K Alper; J S Alper
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

2.  Eugenics and genetic discrimination.

Authors:  N A Holtzman; M A Rothstein
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

Review 3.  State legislative efforts to regulate use and potential misuse of genetic information.

Authors:  J E McEwen; P R Reilly
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

4.  What drives neonatal screening programs?

Authors:  N A Holtzman
Journal:  N Engl J Med       Date:  1991-09-12       Impact factor: 91.245

Review 5.  Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back.

Authors:  K Kreiss; F Miller; L S Newman; E A Ojo-Amaize; M D Rossman; C Saltini
Journal:  Clin Immunol Immunopathol       Date:  1994-05

Review 6.  Genetic testing: employability, insurability, and health reform.

Authors:  M A Rothstein
Journal:  J Natl Cancer Inst Monogr       Date:  1995

7.  Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.

Authors:  R Babul; S Adam; B Kremer; S Dufrasne; S Wiggins; M Huggins; J Theilmann; M Bloch; M R Hayden
Journal:  JAMA       Date:  1993-11-17       Impact factor: 56.272

8.  Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.

Authors:  K Kreiss; S Wasserman; M M Mroz; L S Newman
Journal:  J Occup Med       Date:  1993-03

9.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.

Authors:  E S Tambor; B A Bernhardt; G A Chase; R R Faden; G Geller; K J Hofman; N A Holtzman
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

Review 10.  Chronic beryllium disease: diagnosis and management.

Authors:  M D Rossman
Journal:  Environ Health Perspect       Date:  1996-10       Impact factor: 9.031

View more
  1 in total

Review 1.  Genetic testing and public policy.

Authors:  N A Holtzman; D Shapiro
Journal:  BMJ       Date:  1998-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.